Clinical characteristics of subjects according to the quartiles of LAP in non-obesity N (%), M±SD (N=4,014)
| Variables | Lipid accumulation product (LAP) | Post hoc analysis ( |
||||
|---|---|---|---|---|---|---|
| aQuartile 1 (≤10.51) (N=1,002) |
bQuartile 2 (10.52∼18.64) (N=1,004) |
cQuartile 3 (18.65∼31.82) (N=1,005) |
dQuartile 4 (≥31.83) (N=1,003) |
|||
| LAP | 6.58±2.72 | 14.39±2.35 | 24.51±3.77 | 54.19±3.77 | <0.001 | a<b<c<d |
| Age (years) | 40.91±16.44 | 49.52±16.44 | 55.55±15.84 | 58.49±14.63 | <0.001 | a<b<c<d |
| Men | 328 (32.7) | 373 (37.2) | 420 (41.8) | 487 (48.6) | <0.001 | |
| SBP (mmHg) | 111.23±14.36 | 115.86±16.28 | 120.24±16.78 | 124.29±16.56 | <0.001 | a<b<c<d |
| DBP (mmHg) | 72.14±8.99 | 73.83±9.37 | 75.06±9.34 | 76.69±9.30 | <0.001 | a<b<c<d |
| BMI (kg/m2) | 10.09±1.95 | 21.81±1.67 | 22.59±1.49 | 23.24±1.31 | <0.001 | a<b<c<d |
| WC (cm) | 70.66±5.47 | 77.97±5.08 | 81.76±5.22 | 85.42±5.28 | <0.001 | a<b<c<d |
| TC (mg/dL) | 182.43±31.85 | 187.08±35.14 | 194.73±37.55 | 202.77±39.61 | <0.001 | a<b<c<d |
| TGs (mg/dL) | 62.60±22.91 | 80.01±23.43 | 112.32±30.57 | 211.25±30.57 | <0.001 | a<b<c<d |
| HDL-C (mg/dL) | 62.20±12.60 | 57.45±12.63 | 53.24±11.33 | 47.08±10.87 | <0.001 | d<c<b<a |
| BUN (mg/dL) | 14.40±4.20 | 15.27±4.66 | 15.87±6.00 | 15.84±4.87 | <0.001 | a<b, c, d |
| Crea (mg/dL) | 0.76±0.16 | 0.78±0.18 | 0.81±0.33 | 0.82±0.22 | <0.001 | a, b<c, d |
| FBG (mg/dL) | 91.53±12.93 | 95.58±15.29 | 99.81±18.60 | 106.87±27.78 | <0.001 | a<b<c<d |
| Insulin (μU/mL) | 5.42±3.39 | 6.36±4.61 | 7.78±7.77 | 9.77±7.09 | <0.001 | a<b<c<d |
| MetS | 3 (0.3) | 30 (3.0) | 127 (12.7) | 501 (50.0) | <0.001 | |
| MetS score | 0.31±0.57 | 0.74±0.84 | 1.29±1.00 | 2.56±1.11 | <0.001 | a<b<c<d |
| HOMA-IR | 1.24±0.85 | 1.52±1.22 | 1.97±2.44 | 2.64±2.39 | <0.001 | a<b<c<d |
Abbreviations: See Table 1.
